YC137 at a concentration of 5μM fully abrogated the acquired cell survival advantage consequent to forced expression of TFF3 (Figure 5C), suggesting that TFF3-enhanced HCC cell survival is BCL-2-dependent. This evidence concerns the gene TFF3 and hepatocellular carcinoma.